✦ LIBER ✦

Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia

✍ Scribed by Mario Ojeda-Uribe; Anne Schneider; Isabelle Luquet; Ana Berceanu; Pascale Cornillet-Lefebvre; Eric Jeandidier; Bruno Lioure; Lionel Ades; Laurent Mauvieux; Chantal Himberlin

Book ID: 114795724
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 188 KB
Volume: 89
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2012.01805.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Azacitidine in a patient with newly diag

Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: Outcomes of prolonged therapy

✍ Vasiliki Pappa; Konstantinos Girkas; Constantina Sambani; Sotiris Pagageorgiou; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Karyotype is an independent prognostic p

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

✍ Schoch, C; Kern, W; Schnittger, S; Hiddemann, W; Haferlach, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 166 KB

The stem cell mobilizing capacity of pat

The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial

✍ Keating, S; Suciu, S; de Witte, T; Zittoun, R; Mandelli, F; Belhabri, A; Amadori 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Allogeneic stem cell transplantation in

Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia

✍ de Labarthe, A; Pautas, C; Thomas, X; de Botton, S; Bordessoule, D; Tilly, H; de 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

High numbers of mobilized stem cells in

High numbers of mobilized stem cells in patients with acute myeloid leukemia in first complete remission: good or bad?

✍ de Witte, T 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

Impact of Cytogenetics and Marrow Remiss

Impact of Cytogenetics and Marrow Remission Status on Disease Progression in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Allogeneic Stem Cell Transplantation

✍ E. Koca; R.M. Saliba; M. de Lima; U. Popat; P. Kebriaei; G. Rondon; W. Zhang; S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB